# Novartis — media coverage

Novartis was mentioned 36 times in 15 outlets across 5 countries over the last 12 months. 31% of that coverage was positive and 3% negative.

- Data as of: 2026-10-04 (window: last 365 days)
- Mentions (12 months): 36 (38 all-time)
- Outlets (12 months): 15 in 5 countries
- Average sentiment: +0.190 (31% positive, 3% negative)
- Sector: Pharma

## Coverage over time (mentions per month)

| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 1 |
| 2026-01 | 0 |
| 2026-02 | 1 |
| 2026-03 | 0 |
| 2026-04 | 1 |
| 2026-05 | 5 |
| 2026-06 | 19 |
| 2026-07 | 2 |
| 2026-08 | 7 |
| 2026-09 | 0 |
| 2026-10 | 0 |

## Top outlets (12 months)

| Outlet | Mentions |
|---|---|
|  | 20 |
| biospace.com | 2 |
| finance.yahoo.com | 2 |
| ad-hoc-news.de | 1 |
| cbinsights.com | 1 |
| dentonrc.com | 1 |
| emjreviews.com | 1 |
| en.wikipedia.org | 1 |

## Countries (12 months)

| Country | Mentions |
|---|---|
| US | 20 |
| INT | 13 |
| DE | 1 |
| IN | 1 |
| MY | 1 |

## Share of voice among Pharma peers (12 months)

| Brand | Mentions |
|---|---|
| Eli lilly | 130 |
| Astrazeneca | 78 |
| Pfizer | 64 |
| Johnson & johnson | 59 |
| Novo nordisk | 46 |
| Merck | 44 |
| Sandoz | 41 |
| Moderna | 38 |
| Bayer | 36 |
| Roche | 36 |

## Recent coverage

- [Novartis India Ltd. Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com](https://www.valueresearchonline.com/stocks/43567/novartis-india-ltd/shareholding/) — valueresearchonline.com, 2026-08-31, neutral
- [Novartis stock trades below consensus target as post-earnings digestion continues - ad-hoc-news.de](https://www.ad-hoc-news.de/boerse/news/corporate-news/novartis-stock-trades-below-consensus-target-as-post-earnings-digestion/70026788) — ad-hoc-news.de, 2026-08-31, neutral
- [Novartis Selects Winter Park for New Radioligand Therapy Manufacturing Facility - Orlando Economic Partnership](https://news.orlando.org/blog/novartis-selects-winter-park-for-new-radioligand-therapy-manufacturing-facility/) — news.orlando.org, 2026-08-24, positive
- [Novartis plans $280M facility in Denton to produce ‘next-generation’ cancer treatments - Denton Record-Chronicle](https://dentonrc.com/business/novartis-plans-280m-facility-in-denton-to-produce-next-generation-cancer-treatments/article_b2c8ba86-002b-4eb9-b93c-527a0be1f621.html) — dentonrc.com, 2026-08-20, positive
- [Update: Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent - Yahoo Finance](https://finance.yahoo.com/healthcare/articles/market-chatter-novartis-wins-uk-153302721.html) — finance.yahoo.com, 2026-08-13, positive
- [Novartis - Wikipedia](https://en.wikipedia.org/wiki/Novartis) — en.wikipedia.org, 2026-08-10, neutral
- [Inside Q2’s digital banking funding boom](https://www.cbinsights.com/research/august-6-newsletter/) — cbinsights.com, 2026-08-06, neutral
- [Q2 growth for Novartis as new drugs offset patent cliff - EMJ](https://www.emjreviews.com/emj-gold/news/q2-growth-for-novartis-as-new-drugs-offset-patent-cliff/) — emjreviews.com, 2026-07-21, neutral

Data: VoilàIQ, 2026-10-04. Canonical: https://voilaiq.com/brand-catalog/novartis